Though most graduates are too heavily indebted to give rental insurance serious consideration, the cost of replacing their few belongings may be more than they can absorb.
Millennials who are graduating from college and entering the workforce need to ensure they purchase the right type of health insurance coverage.
Managed care Advantage plans save seniors money - but do they save lives?
Geisinger in Pennsylvania has embarked on a new strategy to attract and retain more patients: give refunds to patients who complain, without asking any questions.
There are plenty of myths linked to disability insurance. Here are some of the worst.
The problems that led Macy's to lower its full-year earnings guidance are more a function of troubled times for department stores than a weakening consumer.
AIG secures $300 million in indemnity reinsurance for mortgage insurance policies issued before 2008, signaling renewed interest in financial products once viewed as untouchable.
Know the score when shopping for a mortgage, especially when it comes to mortgage insurance.
One of American workers' greatest fears is how much they'll spend on long-term health care in retirement. The figures and their recent growth suggest those fears are well-founded.
Auto sales are going through the roof. Before you head to the showroom, read this "survival guide" for buying, insuring and leasing a car.
New technologies and tumbling prices are putting hearing aids on more aging ears.
Failure to wear a seat belt may be the last 'minor' moving violation, as just about anything else will add at least 20% to your insurance premiums.
Warren Buffett's Berkshire Hathaway is scheduled to report quarterly earnings today, but the billionaire CEO has already shared many of the details, including challenges at Burlington Northern.
AIG investors will vote next week on AIG's nomination of John Paulson and a designee of Carl Icahn to its board. The activists had both pushed for a breakup.
Celgene shares are off 16 percent year-to-date and last week's weak guidance did not enthuse the biotech giant's backers.